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Abstract Placebos are commonly defined as ineffective treatments. They are
treatments that lack a known mechanism linking their properties to the properties of
the condition on which treatment aims to intervene. Given this, the fact that
placebos can have substantial therapeutic effects looks puzzling. The puzzle, we
argue, arises from the relationship placebos present between culturally meaningful
entities (such as treatments or therapies), our intentional relationship to the envi-
ronment (such as implicit or explicit beliefs about a treatment’s healing powers) and
bodily effects (placebo responses). How can a mere attitude toward a treatment
result in appropriate bodily changes? We argue that an ‘enactive’ conception of
cognition accommodates and renders intelligible the phenomenon of placebo
effects. Enactivism depicts an organism’s adaptive bodily processes, its intentional
directedness, and the meaningful properties of its environment as co-emergent
aspects of a single dynamic system. In doing so it provides an account of the
interrelations between mind, body and world that demystifies placebo effects.
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Introduction
In a now famous study, Moseley et al. (2002) performed ‘sham arthroscopic
surgery’ on a group of subjects with chronic osteoarthritis of the knee. Moseley
et al. found that most patients receiving the sham surgery, where anaesthetic was
administered and incisions made to the knee, but no arthroscope was inserted and no
rinsing or scraping occurred, recovered knee functions at the same rate of patients
receiving the real surgery. For some patients, this ‘intervention’, bogus by the
standards of medical science, did more to ease chronic and debilitating symptoms
than years of standard treatment and therapy.1
This is a striking example of a placebo effect. Roughly, a placebo is simply a
treatment that isn’t supposed to have therapeutic effects on the condition being
treated; placebo effects are thus surprising beneficial effects that run counter to this
supposition. Correlatively, nocebo effects are negative effects of treatments that are
supposed to be inefficacious.2 In recent years many clinical trials, meta-analyses,
neuroimaging studies and experiments have considerably expanded our knowledge
of such effects, showing them to be pervasive and at times powerful. We know, for
example, that placebo effects are elicited in a wide variety of diseases, ranging from
conditions of pain to some diseases of the nervous system such as Parkinson’s or
migraine; from gastrointestinal and genitourinary dysfunctions to disorders of the
immune and endocrine systems (Benedetti 2014). In a series of experiments, the
neuroscientist Fabrizio Benedetti and his team found that even the most powerful
modern painkillers are substantially less effective when administered surreptitiously
through intravenous injection than when administered in the patient’s full view
(Benedetti et al. 2011). And all but the most recent history of medicine consists
primarily in the history of the placebo effect. Most of the treatments predating the
development of modern European medicine, whether in Greece, India or China, are
seen by modern eyes as ineffectual—at times bizarre—placebos (Majno 1975;
Shapiro and Shapiro 1997)
The prevalence and surprising power of placebos looks puzzling for science-
based medicine. Here, we aim to show that this puzzlement stems from a particular
way of thinking (firmly and understandably entrenched in western culture) about the
mind’s relation to the body and the world, and a corollary view of the nature of
medical science and treatment (Lee 2012). We will argue that an alternative
‘enactive’ conception of the mind/body/world relation (Varela et al. 1991; Di Paolo
1 More recently, Sihvonen et al (2013) demonstrated that sham surgery for degenerative meniscal tears
was as effective as genuine arthroscopic surgery. Harris (2016) contains a fresh compilation of ‘‘placebo
surgery’’ cases.
2 This rough definition of placebo and nocebo effects suffices for our purposes in the paper. Given their
intrinsically oxymoronic nature, providing a more nuanced definition has never proven to be an easy task.
Nunn (2009) surveys existing attempts and despairs that: ‘Every way of looking at the placebo construct
invites criticism because it doesn’t make sense. A placebo is something effective that is inert. Or
something inert that has an effect. That doesn’t make sense of either the word ‘inert’ or the word
‘effective’.’ (1018). Recently, a thorough effort at making sense of these terms on a conceptual level was
made by Howick (2017).
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2005; Thompson 2007) can accommodate and elucidate the phenomenon of placebo
effects.3
The puzzle about placebos
Since the Enlightenment, science has had great success conceiving of and
explaining observable phenomena in broadly mechanistic terms. We live in a
physical universe, governed by determinable laws. All observable phenomena are
products of particular configurations of matter unfolding in law-governed ways. If
we want to understand, predict or control some phenomenon, we need to identify the
physical conditions that give rise to it, and the laws that determine the way it
unfolds.
Among the areas where this paradigm has succeeded most impressively is
medical science. Just like the rest of the universe, we can predict, understand, and
sometimes control, our physical ailments by identifying the physical conditions that
underpin them, and the laws that govern their unfolding. Here, the parts of the
universe most relevant for understanding and treating disease are our bodies.
Medical science becomes the study of human bodies and their constituent
mechanisms and functional constants. Following the rest of physical science, it
operates by reducing the area of study to progressively smaller units and sub-units,
and searching for universal laws and structures of linear causality between different
bodily mechanisms.
This framework provides medicine with a natural criterion for defining the
pathological and the normal. A trait or function is pathological to the extent that it
varies from the mean of its measurement within a given population (Boorse
1977, 1997). Disease is simply a quantitative aberration (an insufficiency or
exaggeration of some sort) of the normal. Having objectified disease in this way, the
role of medical treatment becomes that of restoring a specific abnormal function or
trait to its normal state, and its therapeutic effects are scientifically established (via
clinical trials) according to its capacity to do so (Canguilhem 1989, 2012). In
practice, this means that the analysis of pathology and cure is carried out through
localization, tackling disease at the levels of the organ, tissue, cell and gene,
depending on the disease in question. Like a repairman, the doctor’s job is that of
fixing a mechanical problem.
Placebo effects mystify because they violate current biomedical understanding of
active factors in treatment. In the double-blind randomized clinical trials typical of
3 The label ‘enactivism’ has been applied to a wide variety of views. As we shall see in subsequent
sections, the kind of enactivism that houses our explanation of placebo effects is one that emphasizes the
interrelations between (i) biological organization and sensorimotor interactions, (ii) sensorimotor
interactions and cognition, and (iii) cognition and culturally instituted meaningful structures. Notable at-
tempts to articulate a theory of cognition with this structure can be found in the work of Francisco Varela
(Varela et al. 1991; Weber and Varela 2002), Thompson (2007) and di Paolo (2005). Related views that
emphasise some, but not all, of these interrelations (such as Hurley 1998; Noe¨ 2004, 2012; Hutto and
Myin 2013) are compatible with the treatment of placebo effects we provide here to the extent that they
could be developed to include theoretical emphases on these three sets of interrelations. See Ward et al.
(in press) for a discussion of different forms of enactivism and their interrelations.
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contemporary medical research, placebo groups are supposed to work as controls to
groups receiving the real treatment, because they involve no intervention on the
mechanisms hypothesized to underpin the disease. Given this, the fact that placebos
can lead to substantial therapeutic effects is puzzling. Medical anthropologist Daniel
Moerman suggests an apparently analogous example. Suppose that:
we fabricate some placebo socket wrenches. They look like socket wrenches,
sound like them, feel like them. But we design them so that when you put the
socket over the loose nut and tighten it, the nut will stay loose. We secretly
place these wrenches in the toolboxes of a randomly selected set of mechanics
at the car repair shop. Now, if we discovered that the nuts these mechanics
were working on really did tighten up, we would have good reason to be
surprised. The only thing that can tighten up nuts is a (real) wrench. (Moerman
2002, p.137).
In clinical trials, placebo groups receive a treatment selected in virtue of the
apparent lack of any mechanism linking its effects to the bodily condition requiring
treatment. Against this backdrop, the fact that placebos often have substantial bodily
effects looks as mysterious as the effects of Moerman’s placebo wrenches. If we
understand disease in terms of deviations from the statistically normal functioning
of the body’s processes, and its treatment in terms of interventions upon the body’s
mechanical workings that aim to restore normal functioning, interventions that
result in healing without targeting those underlying mechanics are puzzling.
Of course, placebos do appear to target something—the patient’s beliefs about
whether they are undergoing treatment and thus their expectations about whether
they will get better. But how, in cases of placebo effects, can a mere belief be
causally efficacious? Someone’s false, but sincerely held, belief that their severed
limb will grow back, or that their broken bone is perfectly intact, neither makes their
limb less severed, nor their bone less broken. So why should a false, but sincerely
held, belief that one has had arthroscopic surgery, or that one has been given a
causally efficacious pill, bring about bodily changes that constitute healing? The
puzzle about placebos consists in reconciling a mechanistic conception of the body
and nervous system (and a corollary conception of disease and health) with the
evidence that the patient’s belief in the efficacy of their treatment has a causal effect
on their body, even when this belief is false. From a mechanistic perspective, the
only difference between the recipients of Moseley’s placebo surgery and a control
group who receive no treatment at all is the presence of a false belief on the part of
the former group. But how can the mere presence of a false belief have such
dramatic effects?
Problems with existing accounts
This puzzle, we will argue, doesn’t arise for enactivists. Enactivism provides an
alternative conception of disease and health, and of the relationship between mind
and body, that renders placebo effects unmysterious. Before making our case for
this in the next sections we briefly consider the problems faced by existing accounts
G. Ongaro, D. Ward
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of placebo effects. We do this firstly to show that there is a live puzzle about how to
understand placebo effects, and secondly because—as we shall see—each of the
problematic accounts below contains important insight.
Conditioning
Early attempts to accommodate and explain placebo effects appealed to classical
conditioning (Wickramasekera 1980; Ader 1999; Siegel 2002). Past histories with
objectively neutral objects such as doctors, hospitals, pills and injections, condition
us to respond in ways beneficial to healing when in the presence of those objects.
Thus, being given a pill or an injection with no apparent efficacy for the symptoms
being treated can nonetheless produce a healing response.
However, it seems that placebo effects can occur without conditioning—for
example, the patients in Moseley et al.’s sham surgery did not require prior exposure
to surgery in order to exhibit their marked improvements. There are also studies
suggesting that expectations about the effects of treatment are, in some cases, more
important determinants of placebo effects than prior conditioning. Benedetti et al.
(2003) gave subjects a saline injection after informing them that the injection would
increase the levels of pain they felt—thus inducing an expectation of increased pain.
One trial group, however, had undergone prior conditioning using an analgesic,
intended to forge a conditioned association between the injection and a reduction in
pain. Despite this, both groups in the trial reported an increase in the pain they
experienced, suggesting that expectation was a more powerful determinant of the
effect than prior conditioning.4
Expectations
Partly in response to such problems, expectancy theorists have reinterpreted
conditioning in cognitive terms (Rescorla 1988; Kihlstrom 2002). For these
theorists, conditioned learning about placebos is not directly dependent on the
pairing between the conditioned and unconditioned stimuli, but on the information
contained in the controlled stimulus (Kirsch 1997; Stewart-Williams and Podd
2004). We have, then, the addition of a cognitive variable. This is called
‘expectancy’, and is taken, in existing accounts, to be a consciously accessible
representation of a physiological outcome, which the expectancy is supposed to
trigger. Thus, receiving an injection from a medical professional that we are told
will increase our levels of pain will have this effect because we expect injections to
have the effects that our doctors say they will.
One source of problems for expectancy theorists is evidence suggesting that
conditioned responses to stimuli do play a role in producing placebo effects. For
example, Benedetti et al. (1999) administered the opioid buprenorphine to a group
of patients, producing respiratory depression as a normal side effect. After treating
patients with buprenorphine a few times they gave them a placebo, telling them it
was the same pain medication. Shortly after administering the placebo, they
4 See also Montgomery and Kirsch (1997).
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measured significant respiratory depression. Patients did not form any conscious
expectancy about this particular physiological response—when asked, patients
claimed that they had not noticed the respiratory depression, suggesting that they
lacked expectations about it.5
Partly inspired by such worries, Haug (2011) suggests that placebo effects are
mediated not by conscious expectations, but by aliefs. In addition to the empirical
problems for expectancy theories, Haug argues that any cognitive states mediating
placebo effects have content that need not be consciously accessible, and that can be
inferentially isolated from the contents of the subject’s beliefs. Moreover, states
mediating placebo effects must, it seems, be able to directly cause bodily changes.
This suggests that such states are very different from expectations standardly
construed as beliefs about likely consequences. The content of our beliefs, it is
standardly thought, can usually be brought to conscious awareness, should stand in
appropriate inferential relations to the contents of our other beliefs, and can cause
bodily changes (i.e. behaviour) only in conjunction with another propositional
attitude such as a desire. Haug thus suggests that we should understand placebo
effects as mediated by aliefs, as defined by Gendler (2008a, b). Among other
properties, aliefs are stipulated to directly cause behaviour, and have contents that
are associatively rather than rationally related. This makes them more plausible
candidate states for mediating placebo effects than expectations as standardly
construed.
We agree with Haug’s diagnosis of the problems faced by the expectancy
theorists. But the proposed explanation in terms of aliefs is, as it stands, unhelpful.
The lesson of the failures of conditioning and expectancy theories is that a unified
account of placebo responses must do justice to the appearance that they occupy a
middle ground between conditioned response and the fulfillment of an expectation.
The contribution of an alief-based account is to posit a class of states lying between
automatic physiological responses to stimuli and the inferentially-related, reflec-
tively accessible states posited by orthodox belief/desire psychology. But in this
context the appeal to aliefs just gives a name to the domain we’re puzzling over,
rather than explaining its existence. It still needs to be made intelligible why an alief
about healing should bring about the state of affairs that specifies its content. My
expecting Elvis to enter the room does nothing to bring that physical state of affairs
about—so why should my expecting particular changes in my body bring that state
about? Likewise, if alieving that Elvis is about to enter the room does nothing to
bring that about, why should things be different in the case of my aliefs about my
bodily states? Saying that aliefs can directly cause bodily changes amounts to
stipulating that things are different in the latter case, but without making intelligible
how or why this could be.
5 See also Jensen et al. (2012, 2015) for further studies that problematise expectancy theories, showing
that placebo effects can be elicited outside conscious awareness.
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Evolutionary accounts
Finally, some theorists attempt to explain placebo effects in terms of hypotheses about
their evolutionary function. For example, Humphrey (2002) and Humphrey and
Skoyles (2012) suggests that placebo effects occur when the inhibition of a latent
capacity for self-healing is overridden as a result of perceiving oneself to be in an
environment that affords healing. Fullymobilizing the body’s immune resources has a
highmetabolic cost, soHumphrey hypothesizes an evolved ‘health governor’, capable
of determining whether these resources should be deployed based on the perceived
context. For example, it’s usually better to deploy one’s immune response in the
context of treatment caringly offered by other people than when fleeing a hungry lion.
Thus, we have evolved an automatic brake on our self-healing capacity that is released
only in appropriate contexts. Building on Humphrey’s general framework, Evans
(2003, 2005) suggests that placebos trigger a suppression of an ‘acute-phase’ immune
response via the release of endorphins, and a subsequent reduction in pain and
inflammation. Finally, Steinkopf (2015) argues that some conspicuous symptoms of
immune response (such as pain, swelling and fever) can signal the need for treatment
and care from helpful bystanders, and might have evolved partly for this reason. His
hypothesis is thus that once these symptoms are perceived to have performed their
signaling function—for example when one perceives oneself as undergoing
treatment—they will diminish, regardless of the other effects of the treatment.
We find each of these proposals about the adaptive value of placebo responses
interesting and plausible, and the above suggestions about the biological underpin-
nings of placebo responses might form an important part of a completed account.
However, as they stand, each of these accounts faces problems. For example, there
are many placebo-responsive conditions (such as depression, Parkinsons and
epilepsy) whose biophysiological manifestations appear unrelated to the acute-
phase or inflammatory responses emphasized above by Evans. The diversity of
placebo responses makes it hard to see how a single evolved biological mechanism
could explain them all. Most important, for our purposes, is a residual puzzle
concerning how healing processes are triggered by appropriate contexts. Not all
placebo responses require the presence of caregivers, and the range of contexts
associated with a healing response is much wider (and often unrecognizably more
sophisticated) than those available to our evolutionary ancestors. As we saw above,
the relationship between treatment context and placebo response can neither be a
matter of simple conditioning, nor of explicit expectation. An account in terms of
implicit expectations (such as Haug’s) owes us a story of the content of these
expectations, how they arise, and how they relate to the biological dynamics of
placebo responses. This is what our enactive account aims to provide.
The enactive alternative
Each account above contains important insight. The enactivist agrees with the
evolutionary theorist that placebo responses are grounded in biological processes,
and that they occur in virtue of experiencing oneself as in a context that affords
healing. They agree with conditioning theorists that placebo responses need not be
An enactive account of placebo effects
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mediated by beliefs about the treatment, and that they are a function of the subject’s
history of environmental interactions. But they also agree with expectancy theorists
that placebo responses are dependent, in a way to be specified, on the subject’s
attitude toward the treatment.
According to the account we will provide here, placebos afford healing by shifting
attention from mal-adapted parts of our bodies to (an expanded range of) things we
can achieve with them; they do so in virtue of the culturally inculcated meanings we
perceive in placebos and their contexts. This can happen because the parts of our
bodies, our overall bodily relationship to the environment, and the practically and
culturally meaningful structures within that environment, are all co-emergent and co-
dependent aspects of a single dynamic process. The sections that follow briefly
outline the distinctive and interrelated ways in which enactivists understand the
relationships between: an organism, its parts, and the environment (‘‘Autopoietic
organisation and minimal normativity’’ Section); sensorimotor activity and cognition
(‘‘Adaptivity, cognition and valence’’ Section); adaptive activity and intentionality
(‘‘Enactive attention’’ Section); affect, intersubjectivity, and cognition (‘‘Cognition
is affective’’, ‘‘Cognition is intersubjective’’ Sections). Considering these features of
enactivism lets us see, in turn: the distinctive conception of disease and healing
available to the enactivist (‘‘An enactive conception of disease and healing’’
Section); how the enactivist can make sense of a bodily attentional dimension to
illness and placebo effects (‘‘Somatic attention, health and placebos’’ Section); and
how enactivism can accommodate important findings about cultural determinants of
placebo effects (‘‘Cognition is intersubjective’’ Section). We aim not to provide
arguments that compel assent to these features of enactivism and their theoretical
consequences, only to set out the relevant features of an enactivist framework in
sufficient detail to show that such a framework provides a way of making sense of a
pervasive and puzzling empirical phenomenon.
Organism, environment and cognition
Autopoietic organisation and minimal normativity
Perhaps the most important guiding idea of enactivism is that when we are studying
a living being (or its mind) we are studying an organism, whose organisational
principles and properties differ in fundamental ways from those of a machine. For
enactivists, the defining feature of living organisms is their ‘autopoietic’ organi-
sation. Consider a single cell. It is separated from its chemical environment by a
semi-permeable boundary, and a network of metabolic processes both regulates the
internal constitution of the cell and exchanges matter with its surroundings
(nutrients go in, waste products go out). These processes simultaneously knit the
cell into its environment and render it distinct, creating and sustaining the boundary
that marks it out as an organism. Thompson (2007) summarises:
Thus the cell embodies a circular process of self-generation: thanks to its
metabolic network, it continually replaces the components that are being
G. Ongaro, D. Ward
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destroyed, including the membrane, and thus continually re-creates the
difference between itself and everything else. (p.99)
Living organisms thus interact with their environment in ways that create and
sustain their status as distinct biological entities.
For our purposes here, two properties of this autopoietic organisation merit
special attention. Firstly, the reciprocal, co-productive relationship between
organisms, their constituent parts and processes, and their environments. The
metabolic processes that constitute an organism consist in the activities of its
component parts—but those parts are themselves generated and sustained by the
functioning of the organism which encompasses them. The autopoietic organisation
of the organism renders it distinct from its environment—but this organisation
consists in a dynamic network of processes that is indifferent to that distinction,
spanning the organism/environment boundary whilst at the same time creating and
sustaining it. So, for the enactivist, the parts of an organism, the organism itself, and
the environment with which the organism interacts emerge simultaneously from a
shared dynamic tangle of processes. It is thus essential to living organisms that they
create and sustain their constituent parts and processes, and that their doing so
involves a reciprocal causal relationship with their environment.6
Secondly, note that this organisational structure of living organisms entails that
their functioning entails a kind of minimal normativity—in constituting itself as an
autopoietic unity by creating and sustaining a distinction between itself and its
environment, an organism supplies a standard by which we can evaluate the
functioning of its parts and processes. Qua autopoietic unity, insofar as an
organism’s functioning allows it to persist as an entity distinct from its environment
in the face of external perturbations we may say it’s doing well, or succeeding;
insofar as its functioning fails to sustain its distinction from the environment (as
when a bacterium dissolves into the molecular soup that surrounds it) we may say
it’s doing badly, or has failed. Without the autopoietic organisation that allows an
organism to stand out from its environment these particular standards could not be
applied—there would be nothing to which we could apply them.7
6 Note the conception of ‘environment’ implied here—environment and organism are co-defined, such
that the properties and structures that make up an organism’s environment are that subset of properties
and structures involved in the set of sensorimotor interactions that allow the organism to persist as an
autopoietic unity. A consequence of this is that different kinds of organisms live in different
environments. As we will see later, enactivists hold that the affective and intersubjective constraints on
human/environment interactions mean that our shared human environment incorporates an exponentially
richer range of meaningful properties and structures than the environments of other organisms, and it is
this fact that explains the range and power of placebo effects found in humans. See e.g. Gibson (1979),
p.8, for a famous historical antecedent of this conception of the relationship between organism and
environment.
7 This brief summary of autopoiesis and its consequences suffices for our purposes here. See Maturana
and Varela (1980), Thompson (2007) (ch.5), or Di Paolo (2005) for more. We have been deliberately
cagey about the way in which we think autopoiesis implies normative standards—see the concluding
paragraph of ‘‘Enactive attention’’ Section, below, for more on this.
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Adaptivity, cognition and valence
We might worry (with Di Paolo 2005) that the ‘normativity’ which autopoietic
organisation allows us to impute to an organism’s functioning is of limited use in
grounding an account of cognitive capacities. As defined above, autopoietic
organisation admits of no degrees—an organism’s constituent processes either
succeed in sustaining it as an entity distinct from its environment, or they don’t.
According to contemporary enactivists (Di Paolo 2005; Thompson 2007),8
understanding the biological roots of cognition requires focusing instead on the
related concept of adaptivity. Adaptivity is here defined as an organism’s capacity to
regulate its relationship to the environment (and hereby regulate its internal states—
recall the dynamic tangle above) in ways that help keep itself around as an
autopoietic unity. Unlike autopoiesis, this organisational property of organisms does
permit assessments of their functioning that admit of degrees. When an organism
regulates its functioning in a way that moves it further away from its conditions of
viability, we can say it becomes better adapted to its situation. It is this property of
organisms that endows features of an organism’s environment, and of its
embodiment, with significance for its viability.
Enactivists often illustrate this with the example of a bacterium in a sugar
gradient (Varela 1997; Di Paolo 2005; Thompson 2007). Because of the physical
constitution of a bacterium, sucrose-rich environments help keep its functioning
within the parameters required for it to persist as an autopoietic unity. And because
of the details of its embodiment, the sensorimotor dynamics of its relationship with
its environment ensure it will tend to move away from portions of its environment
with low concentrations of sucrose, towards sucrose-rich areas. According to
enactivists, this sensorimotor capacity of an organism to modulate its relationship to
the environment in viability-sustaining ways is the basis of all cognition. The
relationship between sucrose and the bacterium’s sensorimotor dynamics and
conditions of viability lets us say that sucrose has significance, or value from the
bacterial perspective, and that the bacterium’s path up the sugar-gradient aims at the
sucrose-rich area.
An enactive conception of disease and healing
Above, we suggested that placebo effects currently appear mysterious against a
backdrop of a mechanistic conception of bodies, and a corollary conception of
pathology as statistical deviation of body parts or processes from their mean within
the relevant population. Enactivism helps demystify placebo effects in part by
suggesting an alternative to this quantitative conception of pathology. To see how,
let’s consider a couple of problems for this conception.
Firstly, we can note (with Canguilhem 1989) that it neglects what appears to be
an essential qualitative aspect of disease and health. Statistical deviance looks
plausible as a definition of the pathological only insofar as we usually experience it
8 Both of whom offer their accounts as friendly amendments to the earlier, autopoiesis-centric
formulations of (e.g.) Varela (1997), Weber and Varela (2002).
G. Ongaro, D. Ward
123
in negative terms—for example of lack, or constraint. In cases where this isn’t so,
we are rightly suspicious of the quantitative definition. If, for example, large
numbers of deaf or autistic people lucidly judge that their lives are perfectly happy
and fulfilled with respect to the standards they endorse, we have reason to question
whether they are rightly understood as suffering from an illness or pathology, or as
requiring healing. An enactivist framework naturally accommodates this insight.
We saw above that, for the enactivist, understanding an organism as composed of
essentially distinct parts or components is importantly distortive. Organisms are
self-sustaining unities, dynamically coupled to their environments. Focusing on the
statistical propriety of a trait, function, or body-part in isolation (as the quantitative
conception invites us to do) thus entails losing sight of the facts that make it the case
that we are dealing with an aspect of an organism. As we have just seen, enactivists
are particularly interested in adaptive organisms—those that regulate their
relationship with the environment to keep their functioning within bounds of
viability. And it is this capacity that allows features of an organism’s environment,
its activity, and its embodiment to have meaning or significance from the
organism’s perspective. This suggests a natural explanation of what, for the
enactivist, is misleading about the quantitative conception—in abstracting away
from the role a body-part plays in the dynamic process that constitutes and sustains
the organism as a unity in a meaningful environment, we remove the resources
required to make sense of the essential qualitative aspect of disease and health. For
enactivists, the possibility of things going well or badly from an organism’s
perspective is grounded in the dynamic co-constitution of organism, parts, and
environment. Consequently, understanding a body part in abstraction from these
dynamics involves losing sight of the properties that make it potentially relevant to
the health and flourishing of the organism.
Secondly, Goldstein (1939) makes the related point that medical conditions are
not pathological ‘in themselves’, but in virtue of the ways in which they close down
possibilities for adaptive interactions with the environment. Cancer, for example, is
a disease not because of the statistically abnormal patterns of cellular growth it
entails, but because of the effects those patterns can have on an organism’s
relationship with its environment. As before, enactivists can naturally accommodate
this insight. We saw in ‘‘Adaptivity, cognition and valence’’ Section how enactivist
cognition is rooted in an organism’s capacity to modulate its relationship to its
environment in ways that sustain its conditions of viability. Pathology, then, can be
understood as any condition that affects the dynamic relationship between organism
and environment in a way that moves the organism away from its optimal conditions
of viability. Healing can be understood as any modulation of that relationship that
moves the organism towards those optimal conditions.9 Again, enactivists diverge
from the quantitative conception by insisting that body parts and processes must be
understood as constituents of an adaptive dynamic process in order to understand
their significance for an organism’s flourishing. One important consequence of this
9 See Saborido et al. (2016) for a recent attempt to formulate a naturalistic conception of health and
disease in terms of adaptive dynamics. Carel’s (2007) phenomenological account of illness overlaps with
the characterization we provide here, but is not committed to the enactivist conception of the dynamics
we are in the process of setting out.
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view is that the possibility of healing and pathology arises when, and only when, the
dynamics constitutive of a living cognitive system are in place. Since cognition
consists in the regulation of organismic dynamics in viability-promoting ways,
healing itself is simply an instance of the dynamics fundamental to life and mind.
Enactivists can thus sum up the problems with the quantitative conception as
follows: In understanding disease as the statistically deviant functioning of some
body part or process, and healing as the restoration of statistical propriety, the
quantitative conception understands our bodies and their constituent parts and
processes mechanistically. But this obscures the very conditions of possibility for
sickness and health. Living organisms, not machines, are kinds of things that can be
literally ill, or healed, and enactive accounts of cognition take our status as living
organisms as their starting point. This entails stressing the autopoietic and adaptive
relations between environments, bodies and their parts, and the way in which these
relations create a perspective from which properties of the organism’s activity and
environment have significance. The contrast between the quantitative and the
enactivist conceptions of health stems from the enactivist claim that adaptive
dynamics of living systems bring with them the possibility of applying normative
standards to the functioning of the organism, and thus understanding its constituent
parts and processes as bearing on its flourishing, or otherwise. This is why
enactivists can accommodate the qualitative dimension of illness in a way the
quantitative conception cannot.
The next sections will show how enactivists can build on the material outlined so
far to construct a framework within which placebo effects appear unmysterious. But
we can already glimpse how enactivism might afford an account of the relationship
between body, environment and cognition that does this. Enactivists claim that we
can understand the relevance of body parts or processes to the health of an organism
only by emphasising their dynamic entanglement with the organism as autopoietic
unity, which is in turn coupled to its environment. In ‘‘The puzzle about placebos’’
Section we saw that placebo effects look mysterious because they arise from
interventions that are designed to lack causal efficacy on the afflicted body part or
process. But if an organism, its parts, its environment and its cognitive life are
entwined in the tight web of interrelations the enactivist describes, then touching
one part of this web will make the rest reverberate. Tinkering with the
environmental portion of this web, or with the cognitive processes the web realises,
will have bodily effects. And this makes it intelligible how manipulating cognition
or the environment could be a way of healing the body.10
10 In addition to the possibility of healing the body through intervening on cognition or environment, the
enactive framework sketched so far suggests that healing could also take place through changing the
norms of optimal functioning that the organism enacts. We saw above (‘‘Autopoietic organisation and
minimal normativity’’, ‘‘Adaptivity, cognition and valence’’ Sections) how the dynamics of an organism’s
relationship with an environment bring about a perspective from which it can be assessed as ‘doing well’
or ‘doing badly’. On the conception of healing just outlined, if an organism’s functioning is disrupted
(say, by the loss of a body part), healing can occur by the organism modifying its active relationship with
the environment in ways that move it back towards the original dynamics characteristic of optimal
functioning. But healing could also take place via a shift in what counts as optimal functioning for the
organism—the change in sensorimotor dynamics entailed by the disruption might change the standards of
optimality the organism enacts.
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Adaptivity, attention and intentionality
Enactive attention
Recall (from ‘‘The enactive alternative’’ Section) that we are working towards an
account according to which placebos afford healing by shifting attention from mal-
adapted parts of our bodies to (an expanded range of) things we can achieve with
them. ‘Attention’ here refers just to the way in which the organism is intentionally
directed toward features or properties within its environment. We already hinted (in
‘‘Adaptivity, cognition and valence’’ Section) that enactivists hold that the most
basic form of intentional directedness—what Merleau-Ponty (2012) calls ‘motor
intentionality’—arises from an organism’s adaptive engagement with its environ-
ment. The dynamics of the bacterium’s interaction with its environment bring it
about that particular properties and structures (such as the presence or absence of
sucrose) have significance for it, and allow us to say that the bacterium’s activity is
directed towards particular aspects of its environment. Similarly, enactivists hold
that the dynamics of our interactions with the environment bring it about that we are
intentionally directed towards properties and structures within it, and that those
properties and structures have significance for us as solicitations or impediments to
particular activities or projects. The first important point about the conception of
attention required for our purposes, then, is that it is conceived of as a mode of
intentional directedness toward the environment that arises from the dynamics of
embodied sensorimotor interactions. Attention here is an active and bodily, or
somatic, relation between organism and environment.11
We can bring the second important point into focus by noting that enactivists—
again, following Merleau-Ponty—hold that this directedness always has a
figure/ground structure. Our activity is always directed towards its object through
another process that can itself become the object of attention. Consider, for
example, how our experience is directed when engaged in skillful hammering.
When all goes well, one’s attention is directed through one’s activity towards the
outcome at which it aims. We don’t experience ourselves as manipulating a
hammer, but as acting on a nail. But things can break down—the head flies off the
hammer, involuntarily shifting attention to the bodily interaction with the hammer
that formerly served as the ground of our attention to our task; a muscle cramps,
involuntarily shifting attention to bodily movements that served as the ground of our
manipulations of the hammer. Another example: imagine holding your hand against
a kettle that is gradually coming to the boil. Initially, your experience might be
directed towards the tactile and temperature properties of the kettle. But a point
comes where your attention involuntarily shifts towards a property of your hand, as
the kettle becomes too hot. Bodily properties and processes that previously
functioned as the ground of your intentional directedness towards the environment
now become the figure—the object of your awareness. Your experience of this
gestalt shift involves phenomenal continuity; the property of your hand on which
11 We say a little more about the somatic processes on which this relation depends in ‘‘Cognition is
affective’’ Section.
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your attention is now focused is not experienced as recently and suddenly
instantiated, but as something that previously occupied the background of your
awareness that has, as a result of a gradual change, shifted to the foreground. The
second important point, then, is that the bodily relationship to the environment
characteristic of attention functions as the ground against the backdrop of which the
organism can be intentionally directed towards distal objects.
The final important point is that we should not construe attending to some
property or feature as turning additional cognitive resources toward a feature of the
world or our awareness that was already there. Attending changes and helps
constitute its object. As Merleau-Ponty puts it:
To pay attention is not merely to further clarify some pre-existing givens;
rather it is to realize in them a new articulation by taking them as figures. They
are only pre-formed as horizons, they truly constitute new regions in the total
world. The original structure that they introduce is precisely what makes the
identity of the object before and after the act of attention appear […] attention
is the active constitution of a new object that develops and thematizes what
was until then only offered as an indeterminate horizon. (2012, p.32–3)
This is an extension of a point from ‘‘Autopoietic organisation and minimal
normativity’’ Section, where we saw that features and properties to which an
organism’s activity is geared are constituted by bodily interactions between
organism and environment—they are enacted. In the above kettle example, whilst
there is continuity to our phenomenology, there is also change; our new mode of
attention helps constitute the pain in our hand as an object of awareness.
Momentarily, we will consider how this conception of the links between attention
and bodily activity can add to our understanding of placebo effects. First, we should
briefly clarify our attitude towards a tenet of enactivism that we have handled
delicately thus far. Standardly (e.g. Weber & Varela 2002; Di Paolo 2005;
Thompson 2007), enactivists endorse a thesis of strong continuity with respect to the
relationship between life and mind, claiming that the processes fundamental to
mindedness are merely suitably enriched instances of the processes fundamental to
life. Hence, they claim, bacterial cognition is of a kind with our own, since each
arises from the same sensorimotor dynamic properties. Moreover, most enactivists
(following Jonas 1982; Weber and Varela 2002) think that this involves
phenomenological continuity—the simple adaptive dynamics that characterize a
bacterium’s relationship to its environment support a simple mode of awareness that
differs in complexity, but not necessarily in kind, from our own. We have tried to
present our account in a way that remains neutral with respect to these claims. In
‘‘Adaptivity, cognition and valence’’ Section, for example, we spoke of adaptive
dynamics affording us observers a standard according to which organisms can be
evaluated as doing well or badly, and features of their environment can be accorded
significance. Standardly, enactivists would hold that the relevant dynamics do more
than afford us a way of ascribing such features to the organism/environment
relationship; adaptivity entails that those features really obtain, that they are
immanent in the functioning of the organism. Moreover, these features have a
phenomenological manifestation, however primitive, for the organism. At least one
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of us has reservations about whether such claims of strong continuity are entailed by
the enactivist apparatus presented so far (see e.g. Villalobos and Ward 2015; Ward
and Villalobos 2016). However, the enactivist account of placebo effects does not
depend on strong continuity. Setting simpler organisms aside, as long as it is the
case that for us humans adaptive interactions with our environment embody a form
of motor intentional directedness and involve a phenomenological component, we
have the necessary materials for our enactive account of placebo effects. Giving a
full defense of these enactivist claims is beyond our scope here—but so long as they
are in fact defensible, we have what we need for our account.12
Somatic attention, health and placebos
How does this active, somatic conception of attention help us understand placebo
effects? We saw above (‘‘An enactive conception of disease and healing’’ Section)
that enactivism suggests conceiving of health in terms how body parts and processes
are integrated into adaptive organism/environment dynamics. The above remarks on
attention allow us to expand on this. Borrowing an elegant quote from Leriche,
Canguilhem states that ‘‘health is life lived in the silence of the organs’’ (1989,
p. 102). In health, attention is directed towards solicitations and impediments in the
environment through bodily functioning; the bodily relation to the world functions
as the ground against which opportunities and obstacles show up. But this can be
disrupted. The dynamics characteristic of smooth, unreflective coping can break
down, and attention can be correspondingly redirected toward aspects of bodily
functioning that now show up as impediments to a goal, rather than the ground
against which that goal appears. This is what happens when our attention is drawn
from the nail we are hammering to the cramp in our arm, or from the temperature of
the kettle to the pain in our hand. A natural conception of health for the enactivist,
then, is in terms of the dynamics characteristic of an optimal relationship to the
environment for an organism;13 a natural conception of illness is in terms of
disruption of those dynamics, such that an organism’s activity becomes directed
toward its own bodily states or processes, rather than the distal properties to which
those states and processes usually attune it. We also saw (in ‘‘Adaptivity, cognition
and valence’’ Section) that a system’s capacity to modulate its bodily relationship to
the environment in ways that move it toward conditions of optimality (adaptivity) is
the hallmark of a cognitive system. This allows the enactivist to conceive of healing
12 How might such a defense go? One possibility would be to hold (following McDowell 2007) that
skillful sensorimotor engagement with one’s environment entails an intentional relation only when it can
be integrated with a capacity for reason-giving explanation. One strategy for arguing that such a relation
entails a phenomenological component would be to endorse Fish’s (2009) naı¨ve realism, according to
which the qualitative properties of experience are simply properties of the objects to which one is related
in experience.
13 Importantly, in our human case there is reason to think that we have some say in the nature of these
optimal dynamics, in virtue of our partial capacity to set the goals and projects that we take to be
constitutive of our well-being. This capacity is Taylor’s (1985) subject when he writes of our status as
‘self-interpreting animals’, and it is in virtue of this capacity that the additional means of healing sketched
in n.8, above, obtains. The ways in which this capacity arises is an important topic which we cannot
pursue here—though resources for investigating it are found in Taylor’s work.
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as a process that is simultaneously bodily and cognitive, and fundamental to
cognitive systems.
What does this suggest about placebo effects? We now have a conception of
health in terms of an organism/environment relationship that allows the organism’s
awareness to be directed toward distal properties and features in a way conducive to
its flourishing, and a corollary conception of illness in terms of a breakdown of this
relationship and the resulting direction of awareness towards bodily properties and
processes that impedes optimal interaction with the environment. As noted in ‘‘An
enactive conception of disease and healing’’ Section, conceiving of health and
illness in terms of the dynamic web of organism/environment relations makes it
intelligible how intervening on the environment could be a way of healing the body.
We can now add that the relevant interventions will be those that manipulate the
organism/environment dynamics in ways that provoke exogenous shifts of attention
from the body (and the ways it impedes adaptive interactions) to the environment
(and the ways in which it affords adaptive interactions). For enactivists, then,
placebos can be understood as environmental structures or processes that afford
healing through their capacity to shift attention in this way.14 Think, for example, of
a hobbled distance runner finding herself unexpectedly capable of a sprint finish
when she rounds a corner and encounters the finish line and cheering friends. A
nocebo has the converse effect, prompting suffering or discomfort through drawing
attention to properties of the body; as when cuts or grazes become more painful
once one looks at them. Importantly, the above conception of attention as involving
active constitution of the object of awareness suggests that such attentional shifts
restructure our intentional relation to the object of awareness. Having attention
shifted from the properties of the hot kettle to the properties of one’s hand partly
constitutes the pain in one’s hand as an object of awareness. Likewise, having
attention shifted from bodily properties to the properties of the environment one is
in bodily interaction with can change the intentional object of awareness.
The enactivist account as we have sketched it thus far makes it intelligible why
shifts in attention can alter the way in which we are aware of a body part or
process—can alter its status as an intentional object. But many placebo effects are
striking precisely in virtue of alterations in physical states. The efficacy of placebo
ultrasound in reducing pain and inflammation (e.g. Hashish et al. 1988) is surprising
chiefly in virtue of the physical changes brought about by the sham treatment, rather
than the change in awareness of the swollen area. There is a residual puzzle, then,
about the relationship between intentional and physical changes. Here we can note
that the enactivist grounds an organism’s intentional relation to its environment
(including parts of its body) in terms of the dynamic web of interactions described in
14 An important precedent for this aspect of our account is Frenkel’s (2008) phenomenology of placebo
effects. Like the enactivist, Frenkel draws on Merleau-Ponty to suggest we should understand placebo
responses as a form of motor intentional directedness towards affordances for healing. Our account here is
entirely compatible with Frenkel’s treatment. But we think that the enactivist’s appeal to adaptive
dynamics that span body and world provides extra explanatory purchase on the intimate relation between
mind, body and world characteristic of placebo responses. And, as we will see in the next section,
enactivism allows us to make sense of the affective and cultural dimensions that are central to many –
perhaps all—placebo effects.
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‘‘Organism, environment and cognition’’ Section—thus intentional changes will
coincide with changes in the physical states implicated in those dynamics. A full
explanation of the relationship between intentional and physical changes would,
however, require a completed story of the dynamics of cognition and how they are
implicated in the body and its relation to the environment. Our more modest aim here
is to show how enactivism’s general conception of the dynamic relation between
mind, body and world renders placebo effects intelligible as a phenomenon, and
provides a useful framework in which to investigate them. It does so, as we are now in
a position to see, by revealing them as continuous with other unmysterious
phenomena with which they share an intentional structure. Consider these cases:
• Olivia has to attend an important reception party but cannot afford the particular
designer dress she thinks would be appropriate for the occasion. She feels
anxious, uncomfortable, self-conscious about her own presentability, and unable
to confidently engage with the other guests. She experiences her body as a
problematic object.
• Oliver is a Parkinson patient. His body, which previously allowed him to engage
fluently with the world, now offers him resistance, experienced as fatigue and
stiffness.
Olivia and Oliver are each prevented from optimally interacting with the world
by the ways in which their bodies figure as objects of awareness. Suppose a windfall
allows Olivia to buy the dress she thought appropriate. We would not be surprised to
learn that this alleviated her anxiety (and its physiological manifestations) and
allowed her to interact fluently and confidently with the other guests. Moreover, we
would expect it to do so not by occupying Olivia’s attention during the function, but
by functioning in the background of her awareness, changing her bodily
comportment towards the situation in a way that allows opportunities for fluent
interactions to show up for her. Whilst there is certainly much of philosophical
interest about this case—some of which we will discuss in the next section—the
way in which the dress alleviates Olivia’s anxiety doesn’t raise the kind of puzzles
sketched in ‘‘The puzzle about placebos’’ Section. According to the enactivist, the
efficacy of placebo treatments upon Parkinson symptoms (Benedetti 2014; Goetz
et al. 2008) receives analogous analysis. Providing Oliver with a placebo pill or
surgery places him in a new environmental context that he understands as affording
healing, and in doing so shifts his attention from maladaptive properties of his body
to opportunities for fluent interaction with his environment. In each of these cases
we tinker with the environmental portion of organism/environment dynamics to
alter the distribution of attention between body and world. And in each case the
dynamic links between environment, attention and bodily processes make it
intelligible that these environmental changes can have bodily results.15
15 The analogy presented above further suggests that placebo effects do not have to rest on an explicitly
entertained belief about the reality of treatment in order to work (Olivia’s dress might have its effects
regardless of her explicit beliefs about the reality of the social or aesthetic properties that make it
appropriate for the reception). Interestingly (and in accordance with our account), recent studies have
shown that patients can respond to placebo even when they are told that they are receiving a placebo
(Kaptchuk et al 2010; Carvalho et al 2016). The act of treatment provision itself, coupled (in the
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Some flesh on the bones: affectivity, intersubjectivity and enculturation
These accounts of Olivia and Oliver raise a couple of pressing questions. Firstly, are
they really analogous? We suggested that in each case ‘healing’ occurs through
altering an agent’s implicit grasp of their practical relation to their situation. But it
might be noted that Olivia’s anxiety is an emotional state, and that it’s thus
intuitively clear how this grasp can alter the physiological manifestations of her
anxiety; plausibly, one’s emotional state constitutively depends on such a grasp
(Frijda 1987; Lambie and Marcel 2002). However, symptoms such as Parkinson’s
tremors or limitations in knee function do not appear to be emotional states. So, an
objection might go, the relationship between Olivia’s cognitive and physiological
changes looks unmysterious simply because both pertain to her emotional state; this
doesn’t seem to be the case with physiological changes associated with Parkinson’s
and many other placebo-responsive conditions, so the attempted demystifying
analogy fails.
A second important question concerns our appeal to affordances. Why can
placebos heal? Because, we appear to have claimed, they afford healing. Isn’t this
like ‘explaining’ how the TARDIS works by saying that it affords time travel? An
initial response is to note that we have already made important claims about these
affordances—the previous section claimed that they are taken up via altering the
balance of attention between body and environment, and noted that the enactivist
framework outlined so far implies that such alteration will have bodily effects. But,
we should wonder, how do these affordances get there? And how do we recognize
them? Our enactivist account is incomplete until we have addressed these questions.
To do so, we need to understand why, for enactivists, human cognition is essentially
affective and intersubjective.
Cognition is affective
Enactivists reject the suggested disanalogy between Olivia and Oliver because they
hold that all cognition has an affective component (Thompson 2007; Colombetti
2007, 2014). We saw in ‘‘Organism, environment and cognition’’ Section that
enactivists argue that the sensorimotor dynamics obtaining between an organism’s
embodied activity and its environment suffice for a perspective from which
structures and properties can show up as significant for the organism. A corollary of
this is that the activity constitutive of cognition is never disinterested—since it
directs the organism toward features of the environment that bear (either positively
or negatively) on its flourishing, it always embodies an implicit evaluation of the
organism’s relation to its environment. Moreover, we have seen, this evaluative
relationship depends on how the organism is directed towards its environment
through bodily states and processes. Enactivists thus think that a particular kind of
embodied appraisal (Prinz 2004; cf. Colombetti and Thompson 2007; Colombetti
Footnote 15 continued
mentioned studies) with the message that ‘placebos can work’ communicated by physicians, affords
possibilities of healing and can shift the patient’s attentional state accordingly.
G. Ongaro, D. Ward
123
2014) account of emotion is implied by their view, and that cognition is never
affectively neutral. They agree with appraisal theories of emotion (Arnold 1960;
Scherer et al. 2001) that emotional states depend on a grasp of the way in which
one’s situation bears on one’s projects and wellbeing, and with bodily or James–
Lange theories of emotion (James 1884) in holding that emotional states depend on
awareness of bodily states and processes. As the previous section suggests, these
aspects of emotional states are intimately related—we are directed towards our
situation and its bearing on our projects and wellbeing only through a background
awareness of our bodily states, just as our hammering activity is directed towards its
object through a background awareness of our body.
Enactivists thus reject the separability of cognition and affect, since they hold
that both are products of the same sensorimotoric directedness toward the
environment. The fact that the link between Olivia’s cognitive and bodily states
involves emotion therefore does not provide a disanalogy between her and Oliver.
Instead, it is the way in which enactivism reveals the structural parallels between the
two cases that helps us see placebo responses in Parkinson patients as no more
mysterious than the physiological changes brought about by Olivia’s dress. Noting
the affective component in Olivia’s story helps demystify the relationship between
the cognitive and physiological changes it involves. After all, we know that
emotions are not just intra-cranial states, but events involving the whole organism,
encompassing multiple visceral and motor processes, and regulatory and commu-
nicative networks across nervous, endocrine and immune systems (Damasio 1999;
Purves 2004). For enactivists, these interrelations between somatic, affective and
cognitive processes characterise all cognition. Altering Oliver’s affective and
cognitive relationship to his environment by placing him in a milieu that he takes to
afford healing and improved mobility thus also effects somatic changes.
Cognition is intersubjective
Appreciating the inseparability of cognition and affect sets the stage for the final
feature of enactivism we must appreciate to understand placebo effects. One’s
affective relationship to the environment is, at least for us humans, not set in stone,
but dependent on our history. A situation or object that someone else experiences as
affectively neutral might be highly salient for me in virtue of my history of
embodied interactions with it—think of the different visceral reactions provoked by
the whir of the dentist’s drill, or the smell of warm apple pie. But our embodied
interactions with the environment, and the affective and attentional patterns that
they bring with them, do not develop in a vacuum; they are always shaped and
scaffolded by caregivers and conspecifics, within a particular cultural context. As
Thompson (2007) insists, ‘human subjectivity is from the outset intersubjectivity,
and no mind is an island’ (p.383). Echoing attachment theory (Bowlby 1988), Noe¨
(2009) illustrates:
A two-way exchange arises between child and mother that provides the setting
within which the child develops both physiologically and psychologically. A
child learns to restore its own calm or comfort by being calmed or comforted
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by the mother. The child’s basic physiological processes – burping, for
example – are facilitated for the baby by the mother. The caretaker
manipulates the child’s posture, raising her into a sitting position, now setting
her down in a prone position, either to arouse the child or prepare her for sleep.
The caretaker directs the child’s attention to this or that and manipulates
things for the child … In a very real sense, the baby-caretaker ‘‘dyad’’ is a
unity from which the child only gradually emerges as an individual. (p.50)
In emphasizing the role of these patterns of embodied interaction to psycholog-
ical development, enactivists emphasize the package of innate capacities that
Trevarthen (1979) called ‘primary intersubjectivity’—perceptual sensitivity to
facial expressions, eye gaze, gestures and tones of voice, and the ability to
coordinate behavior in response to these. During development, capacities to gear
behavior to another’s gaze and gesture give rise to capacities to share attention and
to have one’s attention directed in particular ways (e.g. Gallagher 2008; Noe¨ 2009;
De Jaegher and Di Paolo 2007).16 As we grow up, socially scaffolded habits thus
develop in the ways particular objects, situations and events solicit attention and
affectively engage us. In shaping patterns of sensorimotor interaction with the world
in this way, enactivists think, enculturated embodied interactions shape the
dynamics determining our intentional, attentional and affective relationship to the
world.17 These interactions can thus teach us to experience, viscerally and
immediately, objects as alluring or repulsive, situations as comforting or threaten-
ing, and styles of behavior or comportment as reassuring or unnerving. This
plasticity in our habits of embodied interaction, and the attentional and affective
concomitants of those habits, is not limited to early childhood—it is a permanent
feature of our lives. The ways we distribute attention around features of our world,
and the patterns of embodied affective responses those distributions entail, are
constantly being tweaked, reinforced and renegotiated.
This feature of the enactivist framework does important work in answering a
puzzling question with which we began this section—where do the healing
affordances in terms of which we explain placebo effects come from? An affordance
is a property of an organism’s environment that obtains in virtue of the relationship
between organism and environment18—chairs, for example, afford sitting to humans
because of the relationship between human anatomy and chair design. In non-
placebo cases of treatment and recovery, there is no mystery as to why the healing
affordance obtains—we have enough understanding of the relationship between the
physical, chemical or biological properties of the treatment and those of the target
condition to make this intelligible. Placebo effects are puzzling because of the
16 For example, Fuchs and de Jaegher (2009) suggest (echoing Vygotsky 1978) that ‘Originally, pointing
is only a simple but incomplete grasping movement directed towards a desired object. The child’s failed
reaching may provoke a helping reaction from the caregiver… The individual reaching movement can
then turn into a ‘gesture for others’. The meaning of reaching changes and develops into a new possibility
for interacting with the (social) world: pointing.’ (480).
17 Again, the enactivist’s emphasis on the priority of shared intersubjectivity in a developmental account
of our mature experience is anticipated and partly inspired by Merleau-Ponty (1964, 2010).
18 For discussion and a dissenting view, see Chemero (2003). Our account is, as far as we can tell, neutral
with respect to the various proposals about the metaphysics of affordances Chemero surveys.
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apparent absence of such intelligibility. This is just to restate ‘‘The puzzle about
placebos’’ Section’s puzzle about placebo effects in the language of affordances.
We have just seen how, for the enactivist, socially scaffolded habits of embodied
interaction simultaneously give rise to patterns of somatic changes and concomitant
distributions of attention. These habits, formed through our history of interactions
with medical practitioners, treatments and apparatus, explain why the mere presence
of an appropriate medical context can be enough to trigger the distribution of
attention—away from the body and back towards the environment (Sect. ‘‘Somatic
attention, health and placebos’’)—and corollary somatic changes (Sects. ‘‘Enactive
attention’’, ‘‘Somatic attention, health and placebos’’, ‘‘Cognition is affective’’) that
are characteristic of healing for the enactivist (Sects. ‘‘An enactive conception of
disease and healing’’, ‘‘Somatic attention, health and placebos’’). The healing
affordances of placebos, then, obtain in virtue of the meaning we perceive them to
have in virtue of our history of enculturated embodied interaction, and the fact that
being intentionally directed towards a meaningful structure in the environment is a
bodily and affective relation that entrains specific somatic and attentional patterns.
Oliver’s bodily response to the placebo Parkinson’s treatment is thus explained in
the same way as Olivia’s embodied response to wearing the designer dress—both
treatment and dress prompt new ways of attending to the world that are dynamically
intertwined with specific bodily and affective processes; both can do this in virtue of
the culturally inculcated meanings they are perceived to have in virtue of a history
of embodied interactions.
There is a wealth of empirical data on the cultural variability and determinants of
placebo effects that the enactive account is thus well placed to explain. For example,
the facts that branded or expensive placebos are more effective than non-branded or
cheap ones (Branthwaite and Cooper 1981; Waber et al. 2008; Espay et al. 2015)
look difficult to explain without the enactivist’s focus on the interplay between
culturally scaffolded perceptions of meaning and patterns of bodily response.
Likewise, the enactivist emphasis on how culturally situated interactions shape the
bodily dynamics that are recruited in placebo effects suggests how we might frame
explanations of the relationship between the size of the effect and the mode of
treatment. For example a meta-analysis of migraine treatment trials has found that
placebos administered through injection are on average more powerful than oral
placebos (de Craen 2000). The respective culturally mediated perceptions of the
power of pills and injections might be invoked by the enactivist to explain these
results (see e.g. Payer 1996). Finally, a classic instance of placebo responses to
visual meaning is relative to drug colour. Stimulants work better if they are red,
orange or yellow, whereas sedatives are most effective if they are blue (e.g. de
Craen et al. 1996). The reason for this can be sought in the meanings generally
attributed to ‘hot’ and ‘cold’ colours, which commonly induce alertness and
tranquility respectively. There is, however, an intriguing exception to this pattern.
Cattaneo et al. (1970) showed that for Italian men (but not women) blue placebo
pills tend to inhibit sleep rather than promote it. How might this puzzling outlying
result be explained? Moerman (2002) suggests that we find an explanation in the
distinctive culturally inculcated meaning that blue has for most Italian men—as the
colour of Gli Azzurri, the national soccer team, the somatic and attentional habits
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built up around blueness are more likely to be skewed towards arousal than sedation
for this particular demographic.19
Conclusion
The puzzle about placebos arises from the relationship they present between
culturally meaningful entities (treatments or therapies), our intentional relationship
to the environment (implicit or explicit beliefs about a treatment’s healing powers)
and bodily effects (placebo responses). How can a mere attitude toward a treatment
result in appropriate bodily changes? Enactivism is uniquely placed to address this
puzzle because of its insistence on the fact that the parts of our bodies, our overall
bodily relationship to the environment, and the practically and culturally meaningful
structures within that environment, are all co-emergent and co-dependent aspects of
a single web of dynamic relations. If the dynamical underpinnings of mind, body
and culture are inseparably intertwined as enactivists suggest, there is no mystery as
to why tinkering with cultural and cognitive aspects of this dynamic system should
have bodily effects. The previous sections have sketched how, for the enactivist, our
cognitive lives emerge from a culturally embedded web of dynamic autopoietic and
sensorimotor processes that span brain, body and world to knit us into a meaningful
environment. As we develop and navigate the world, with the help of others,
stable patterns and trajectories emerge in these dynamics—paths, or tracks, are laid
down (Varela et al. 1991)—and some of these stable patterns manifest themselves
as bodily affective and attentional habits in our responses to the world. Placebo
effects, we have suggested, occur when a perceived property of our environment
triggers some such habit in a way that entails a pattern of bodily changes that is
characteristic of healing. Placebos thus afford healing by shifting attention from
mal-adapted parts of our bodies to (an expanded range of) things we can achieve
with them, and do so in virtue of the culturally inculcated meanings we perceive in
placebos and their contexts.
Returning to the problematic theories we surveyed in ‘‘Problems with existing
accounts’’ Section, we can see how the enactivist view can preserve the merits of
each while avoiding their difficulties. Like the evolutionary theorist, enactivists hold
that placebo effects must be understood with reference to our status as biological
organisms—specifically, as organisms characterized by the adaptive and autono-
mous dynamics described in ‘‘Adaptivity, cognition and valence’’ Section, and the
entanglement of an organism, its parts, and the environment that this implies. But
the enactivist is not committed to the existence of a single mechanism underlying all
placebo effects, and has a built-in answer to the question of how healing is triggered
by the perception of an appropriate context. This answer avoids the problems that
19 Other relevant examples here include: Moerman’s (2000) work on the cross-cultural variability of
placebo responses to high blood pressure, and the possibility of explaining this in terms of Payer’s (1996)
anthropological studies of cultural variability in attitudes towards, and diagnosis and treatment of, heart
and circulatory diseases; Moerman’s (2013) account of the way a gradual increase in the placebo-
responsiveness of depression has tracked the way in which depression and its treatment has been
portrayed in popular culture.
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face conditioning and expectancy accounts by appealing to an embodied intentional
relation to the perceived context that lies between conditioned response and explicit
expectation. As we have seen (Sects. 5, 6), enactivists appeal to the way a history of
socially scaffolded embodied interactions gives rise to habits of somatic and
attentional response that are fundamentally bodily while simultaneously entailing a
mode of intentional directedness towards the environment. Like an account in terms
of aliefs (Haug 2011), then, enactivists hold that the cognitive relationship to the
therapeutic context that explains placebo effects is more than a conditioned
response, but less than a fully-fledged (articulable, inferentially promiscuous) belief.
But the enactivist framework allows us to say more about just what this relation
consists in: it is an embodied mode of intentional directedness towards the
environment that encompasses affective and attentional components.20 Those
components, coupled with an enactive conception of healing (Sects. ‘‘An enactive
conception of disease and healing’’, ‘‘Somatic attention, health and placebos’’) make
it intelligible why the perceived significance of a treatment can result in placebo (or
nocebo) effects. Finally, appreciating the role of intersubjectivity and enculturation
in establishing the dynamics constitutive of cognition allows the enactivist to
accommodate important findings about the cultural determinants of placebo effects
(‘‘Cognition is intersubjective’’ Section), and make sense of the unique interplay
between culture, cognition and embodiment that characterizes them.21
We should once again be clear about the explanatory scope of our account here.
The utility of enactivism for understanding placebo effects stems from its general
features as a paradigm for understanding cognition. By linking the understanding of
the efficacy of a treatment in terms of socially-scaffolded habits of somatic
attention, and by grounding those habits in dynamics encompassing both body and
world, enactivism makes it intelligible why an understanding—implicit or
explicit—of the efficacy of a treatment or therapeutic context can have substantive
effects on one’s body, and on one’s capacities for environmental interaction. We
have tried to do just enough here to sketch the features of enactivism required to
demystify placebo effects in this way. A full enactivist explanation, however, would
have to elucidate the specific bodily and interactive processes underlying the
somatic and attentional patterns that our account schematically describes. This is
20 In fact, one of Gendler’s original characterisations of aliefs (2008b) emphasises their status as
affectively-laden states, tied directly to behaviour, which can be the results of socially scaffolded habits—
see her discussion of implicit associations. Focusing on these properties of aliefs brings out the
compatibility between the enactive approach we present here and a suitably developed alief-based
account of placebo effects. The key contribution of the enactive account is to make these properties of
affect, bodily interaction and social scaffolding central, and to house them within a conception of the
dynamic relation between mind, body and world that renders intelligible their mutual influence in cases of
placebo effects. Thanks to an anonymous reviewer for prompting clarification here.
21 In an important recent article Alfano (2015) argues that placebo effects can be caused by one of three
mechanisms: conditioning, expectation, or somatic-attentional feedback loops, and that on this basis there
is little scientific or clinical utility in viewing ‘placebo effects’ as a unified phenomenon. Instead,
individual effects should be studied and theorised in their own terms, and implications for informed
consent should be considered in light of the particular mechanism implicated. The enactive account
differs in holding that these mechanisms are intertwined: the ‘expectations’ involved in placebo effects
are understood in terms of habits of somatic attention, which are most often inculcated by a past history of
socially-scaffolded interactions.
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what would be required for an explanation of why specific shifts in somatic attention
cause particular bodily changes—i.e. for an account of particular placebo effects,
rather than an account that aims at rendering these effects intelligible in general.
Supplying such an explanation is not something we have attempted here. Part of
enactivism’s appeal, though, is its provision of a framework within which these
issues can be addressed. It might be, for example, that the biological processes
mentioned in ‘‘Evolutionary accounts’’ Section, above—Evans’ (2003, 2005) acute-
phase response, Steinkopf’s (2015) immune reaction—make important contribu-
tions to the dynamics of many placebo effects. Recent attempts to explain placebo
analgesia (Bu¨chel et al. 2014) and ‘hysterical’ or psychogenic sensory and motor
symptoms (Edwards et al. 2012) in terms of Bayesian models of neural organization
look nicely compatible with the enactive framework here. And finally, existing
enactivist work by Barandiaran and Moreno (2006, 2008; following Edelman 1987)
might house an explanation of the boundaries of the range of placebo-responsive
conditions. They distinguish the Nervous System of the Interior (comprising the
neuroendocrine system, limbic system and autonomic nervous system) from a
Sensorimotor Nervous System, where the former is responsible for the adaptive
control of neural and bioregulatory organization, the latter for adaptive sensorimotor
interaction. Nonetheless, these two systems are dynamically coupled and it is the
dynamics encompassed by this coupling that, according to Barandiaran and Moreno,
demarcate the boundaries of a cognitive system. If such a view were correct, then it
would naturally suggest that conditions will be placebo-responsive to the extent to
which they are implicated in this set of dynamics.
We hope to pursue these attempts to specify the biological underpinnings of the
enactive account in future work. Our claim in this paper, though, is that each of
these proposals can only contribute to a demystification of placebo effects insofar as
it functions to describe one part of the broader web of dynamic relations between
mind, body and world, between affect and cognition, and between self and society
that we have described here. Sketching the structure of the dense web of
interconnections that obtain between these phenomena lets us see them as co-
emergent aspects of a single dynamic system, and thus removes the puzzle about
their interrelations that makes placebo effects look mysterious. We thus think that
enactivism represents an attractive option for making sense of a pervasive and
important phenomenon. Enactivism shows us how to demystify placebo effects, and
reveals new avenues for thinking about health and treatment. And it does so by
showing us a new and fruitful way of putting mind, body and world back together
again.
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